Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2006Annual Review of Pathology Mechanisms of Disease

Spectrum of Epstein-Barr Virus–associated Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJeffery L. KutokNKT Therapeutics (United States)FWF WangHarvard University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kutok et al. (2006) studied this question.

synapsesocial.com/papers/6a73b396f82dff6409279fdchttps://doi.org/10.1146/annurev.pathol.1.110304.100209
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R1989 · 85 citations
  2. 2<i>In situ</i> detection of Epstein–Barr virus in non‐small cell lung carcinomas1995 · 67 citations
  3. 3Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD231990 · 183 citations
  4. 4Genetic Evidence that EBNA-1 Is Needed for Efficient, Stable Latent Infection by Epstein-Barr Virus1999 · 134 citations
  5. 5Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation1997 · 194 citations